Global ICSI Injection Micropipettes Market Growth 2026-2032

October 2026 | 164 pages | ID: G04400DC8DB8EN
LP Information

Abstracts

The global ICSI Injection Micropipettes market size is predicted to grow from US$ 37.88 million in 2025 to US$ 55.37 million in 2032; it is expected to grow at a CAGR of 5.6% from 2026 to 2032.

ICSI Injection Micropipette is a specialized micromanipulation tool used in assisted reproductive laboratories for intracytoplasmic sperm injection. It is typically manufactured from fine glass capillary tubing with a sharp, beveled or spiked tip and is operated together with a micromanipulator and microinjection system. Its primary function is to aspirate and control a selected and immobilized single sperm under microscopic observation, penetrate the zona pellucida and oolemma of a stabilized oocyte, and release the sperm directly into the ooplasm to complete intracytoplasmic sperm injection. Product design focuses on tip configuration, lumen geometry, taper profile, bending angle, surface finish and manufacturing consistency to provide reliable sperm handling, controlled oocyte penetration and precise cytoplasmic injection while minimizing mechanical damage to the oocyte. ICSI micropipettes are specialized consumables for assisted reproductive micromanipulation and are functionally distinct from holding pipettes, which are used to stabilize the oocyte during the injection procedure.

Key Findings

ICSI accounts for around 73% of fertilization treatments worldwide and remains the dominant assisted fertilization technique

Mainstream international channel prices are approximately US$18–20 per micropipette, commonly supplied in packs of ten

Spiked designs and inner diameters below 6 ?m form the core configuration of mainstream clinical ICSI micropipettes

Fertility clinics and IVF centers constitute the primary downstream users, while hospital reproductive centers provide another major demand base

Market Trends

The ICSI Injection Micropipette market is evolving from basic glass injection tools toward highly standardized microtools optimized for reproducibility, lower oocyte trauma and embryologist-specific handling preferences. Major suppliers increasingly offer multiple combinations of spike design, lumen diameter, taper geometry, bend angle and tip-to-bend distance rather than a single universal specification. Long parallel-wall and slim designs are being developed to improve fluid control and reduce entry diameter, while rigid short-taper designs remain important for users seeking greater puncture stiffness. Large-bore models address surgically retrieved sperm, and flat-tip or dedicated Piezo injection pipettes are expanding the technical range of the market. Manufacturing is also becoming more controlled: CooperSurgical uses automated production and repeated dimensional inspection, while Kitazato and ASTEC emphasize individually inspected precision manufacturing and ICSION offers customized specifications. Cleanroom manufacture, individual sterile packaging, traceability, MEA and endotoxin testing are increasingly becoming core purchasing considerations rather than secondary features.

Market Dynamics

Drivers

Demand is fundamentally supported by the large and recurring global ART treatment base and the high penetration of ICSI within assisted fertilization. ESHRE reports more than three million registered ART cycles annually worldwide and estimates actual activity at around four million cycles after allowing for incomplete registry coverage; ICSI accounts for about 73% of fertilization treatments. Male-factor infertility remains the core clinical foundation for ICSI, while previous poor or failed fertilization and selected use after oocyte cryopreservation provide additional procedure demand. Because ICSI requires direct sperm aspiration and oocyte injection through a precision microtool, each expansion in the number of ICSI-performing embryology laboratories generates recurring demand for sterile single-use injection micropipettes.

Restraints

The market is constrained by the already-high penetration of ICSI, slowing ART growth in some mature markets and the relatively low value of each disposable micropipette. ESHRE notes that ART cycle growth in many developed countries has historically been in the mid- to high-single-digit range but is showing signs of moderation, while CooperSurgical also reported periods of softer fertility activity during 2025. In addition, broader use of ICSI is not automatically supported for every non-male-factor IVF cycle; the 2026 ASRM committee opinion continues to distinguish clearly indicated ICSI from routine use in patients with normal semen parameters. These factors limit the extent to which growth can be generated simply by increasing ICSI penetration, making treatment volume, geographic expansion and supplier share gains more important.

Opportunities

The strongest opportunities lie in geographic expansion, localized manufacturing and increasingly differentiated microtool designs. Major suppliers are expanding distribution into North America, Europe and Asia, while Chinese manufacturers such as VitaVitro, DEWIN and Minvitro have established domestic ICSI injection or micromanipulation product lines, creating additional substitution opportunities in a market historically led by imported microtools. Product-level opportunities are emerging around lower-trauma slim designs, customized dimensions, large-bore pipettes for surgically retrieved sperm and Piezo-compatible injection pipettes. ICSION already supplies dedicated Piezo injection models and CooperSurgical offers flat-tip products for Piezo-ICSI, while DEWIN also includes Piezo tools within its micromanipulation portfolio. Customized production is particularly attractive because embryologists often maintain strong preferences for taper stiffness, fluid response, spike shape and bend geometry.

Challenges

ICSI micropipettes are structurally simple but demanding to manufacture consistently because minute variations in inner diameter, bevel, spike formation, taper length, bend angle or surface defects can materially change handling characteristics during microinjection. Suppliers must therefore combine precision glass processing with cleanroom control, dimensional inspection, sterilization and embryo-compatible biological testing. CooperSurgical performs full visual inspection throughout production and uses gamma sterilization together with MEA and LAL testing, while Labotect uses individually sterile packaging and validated electron-beam sterilization. Another challenge is that embryologist preference is highly operator-specific: flexible long-parallel tapers, rigid short tapers, spiked tips and non-spiked tips can all be preferred in different laboratories. This limits complete SKU standardization, increases high-mix manufacturing requirements and makes clinical familiarity, training, distributor support and reliable supply important competitive factors alongside price.

Industry Chain Analysis

The upstream chain is centered on high-purity borosilicate glass capillary tubing, polymer holders and protective packaging, precision forming and inspection equipment, cleanroom infrastructure and sterilization services. Midstream production involves capillary cleaning, heating and pulling, taper formation, lumen control, beveling and spike fabrication, bending, polishing, dimensional inspection, cleaning, sterile packaging and biological quality control. CooperSurgical explicitly identifies cleaning, heating and sonication of borosilicate capillaries as part of its process, while VITROMED manufactures injection pipettes from specially cleaned borosilicate glass under cleanroom conditions. Finished products reach users through global direct-sales organizations and specialist IVF distributors, with independent fertility clinics, IVF centers and hospital reproductive medicine laboratories forming the principal clinical customer base and academic or research laboratories representing a smaller specialized segment. The value added is concentrated less in raw glass cost than in precision processing, process reproducibility, quality assurance, regulatory compliance and dependable global distribution.

Segment Insights

By tip configuration, spiked ICSI micropipettes remain the mainstream architecture. CooperSurgical states that most of its ORIGIO ICSI micropipettes use fine spikes, while Vitrolife and Kitazato maintain extensive spiked product ranges; non-spiked products remain relevant for embryologists preferring a sharp bevel without an additional spike. By inner diameter, products below 5.0 ?m and those from 5.0 to below 6.0 ?m cover the core conventional ICSI range, reflecting the need to balance sperm aspiration, fluid control and a small oocyte entry point. Products at 6.0 ?m and above form a more specialized segment, including designs intended to facilitate handling of surgically retrieved sperm or spermatids. By taper design, long parallel-wall products emphasize fine fluid control and flexibility, short parallel-wall products provide a different balance between control and stiffness, and rigid-taper designs serve embryologists who prefer greater tip rigidity during penetration. The continued coexistence of these designs indicates that operator preference and laboratory technique remain important determinants of product selection.

Downstream Market Opportunities

Independent fertility clinics and IVF centers account for the principal commercial demand because ICSI is performed routinely in dedicated embryology laboratories equipped with inverted microscopes, micromanipulators and injection systems. Hospital-based reproductive medicine centers constitute another important customer segment, particularly in markets where ART services are concentrated in university hospitals, maternity hospitals or large medical systems. Academic and research laboratories represent a much smaller but technically important market for micromanipulation research, embryology training and method development. Future downstream opportunities are increasingly associated with large IVF clinic groups seeking standardized consumables across multiple laboratories, expansion of ART capacity in emerging markets, increasing treatment of complex male-factor infertility and greater demand for product traceability and consistent handling performance. Specialized clinical scenarios such as surgically retrieved sperm and Piezo-ICSI also support higher product differentiation even though they remain smaller than conventional ICSI.

Regional Insights

Europe and North America remain major high-value markets for ICSI Injection Micropipettes because of their mature ART infrastructure, extensive clinic networks and established use of regulated single-use laboratory consumables. Europe represents an exceptionally large documented ART base, while the United States combines substantial procedure volume with relatively high consumable pricing. Asia-Pacific provides the largest long-term volume opportunity through major ART markets including China and Japan, although near-term treatment growth can vary significantly by country. ESHRE identifies China at around one million ART cycles annually and Japan as one of the world's most active officially reported ART markets, while Kitazato identifies the United States, Europe, China and other overseas markets as strategic areas for continued expansion. Regional competition is also becoming more localized: European and North American brands retain strong premium positions, while Chinese suppliers are broadening domestic ICSI microtool portfolios and international registrations.

Competitive Landscape Analysis

The competitive landscape combines diversified global ART platforms with highly specialized micropipette manufacturers and increasingly capable regional suppliers. CooperSurgical has one of the strongest manufacturing positions, producing more than 1.5 million ORIGIO micropipettes annually across ICSI and other micromanipulation applications, while Vitrolife and Kitazato combine ICSI microtools with broader IVF consumable portfolios. Nexpring Health has emerged as an important consolidated ART platform incorporating Cook Reproductive Health, Hamilton Thorne, Gynemed, Gyn?tics, IVFtech, Planer and Irvine Scientific. Sunlight Medical, VITROMED, ASTEC, Labotect, Microtech IVF, Synga, ICSION Medical, ARSCI and Optimas compete through specialist microtool know-how, customization and embryologist-oriented designs. Chinese producers including VitaVitro, DEWIN, WEGO Shingene Medical, Lingen Precision Medical Products and Minvitro are strengthening domestic supply and widening the competitive field. Competition therefore centers on dimensional consistency, tip design, biological safety testing, clinical familiarity, specification breadth, distributor reach and reliable supply rather than on price alone.

Report Scope

LP Information, Inc. (LPI) ' newest research report, the “ICSI Injection Micropipettes Industry Forecast” looks at past sales and reviews total world ICSI Injection Micropipettes sales in 2025, providing a comprehensive analysis by region and market sector of projected ICSI Injection Micropipettes sales for 2026 through 2032. With ICSI Injection Micropipettes sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world ICSI Injection Micropipettes industry.

This Insight Report provides a comprehensive analysis of the global ICSI Injection Micropipettes landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on ICSI Injection Micropipettes portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global ICSI Injection Micropipettes market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for ICSI Injection Micropipettes and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global ICSI Injection Micropipettes.

This report presents a comprehensive overview, market shares, and growth opportunities of ICSI Injection Micropipettes market by product type, application, key manufacturers and key regions and countries.

Market Segmentation

Segmentation by Type:

• Spiked
• Non-Spiked

Segmentation by Inner Diameter:

• <5.0 ?m
• 5.0–<6.0 ?m
• ?6.0 ?m

Segmentation by Taper Design:

• Long Parallel-Wall
• Short Parallel-Wall
• Rigid-Taper

Segmentation by Application:

• Fertility Clinics and IVF Centers
• Hospital-Based Reproductive Medicine Centers
• Academic and Research Laboratories
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• CooperSurgical
• Nexpring Health
• Vitrolife
• Kitazato
• Sunlight Medical
• VITROMED
• ASTEC
• Labotect
• Thomas Medical
• Microtech IVF
• Synga
• ARSCI
• Optimas
• ICSION Medical
• Monash Biotech
• Reproline medical
• TechBruein
• SASOmed
• VitaVitro
• DEWIN
• WEGO Shingene Medical
• Lingen Precision Medical Products
• Diagens Bio
• Minvitro

Key Questions Addressed in this Report

• What is the 10-year outlook for the global ICSI Injection Micropipettes market?
• What factors are driving ICSI Injection Micropipettes market growth, globally and by region?
• Which technologies are poised for the fastest growth by market and region?
• How do ICSI Injection Micropipettes market opportunities vary by end market size?
• How does ICSI Injection Micropipettes break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global ICSI Injection Micropipettes Annual Sales 2021-2032
  2.1.2 World Current & Future Analysis for ICSI Injection Micropipettes by Geographic Region, 2021, 2025 & 2032
  2.1.3 World Current & Future Analysis for ICSI Injection Micropipettes by Country/Region, 2021, 2025 & 2032
2.2 ICSI Injection Micropipettes Segment by Type
  2.2.1 Spiked
  2.2.2 Non-Spiked
  2.2.3 ICSI Injection Micropipettes Sales by Type
    2.2.3.1 Global ICSI Injection Micropipettes Sales Market Share by Type (2021-2026)
    2.2.3.2 Global ICSI Injection Micropipettes Revenue and Market Share by Type (2021-2026)
    2.2.3.3 Global ICSI Injection Micropipettes Sale Price by Type (2021-2026)
2.3 ICSI Injection Micropipettes Segment by Inner Diameter
  2.3.1 <5.0 ?m
  2.3.2 5.0–<6.0 ?m
  2.3.3 ?6.0 ?m
  2.3.4 ICSI Injection Micropipettes Sales by Inner Diameter
    2.3.4.1 Global ICSI Injection Micropipettes Sales Market Share by Inner Diameter (2021-2026)
    2.3.4.2 Global ICSI Injection Micropipettes Revenue and Market Share by Inner Diameter (2021-2026)
    2.3.4.3 Global ICSI Injection Micropipettes Sale Price by Inner Diameter (2021-2026)
2.4 ICSI Injection Micropipettes Segment by Taper Design
  2.4.1 Long Parallel-Wall
  2.4.2 Short Parallel-Wall
  2.4.3 Rigid-Taper
  2.4.4 ICSI Injection Micropipettes Sales by Taper Design
    2.4.4.1 Global ICSI Injection Micropipettes Sales Market Share by Taper Design (2021-2026)
    2.4.4.2 Global ICSI Injection Micropipettes Revenue and Market Share by Taper Design (2021-2026)
    2.4.4.3 Global ICSI Injection Micropipettes Sale Price by Taper Design (2021-2026)
2.5 ICSI Injection Micropipettes Segment by Application
  2.5.1 Fertility Clinics and IVF Centers
  2.5.2 Hospital-Based Reproductive Medicine Centers
  2.5.3 Academic and Research Laboratories
  2.5.4 Others
  2.5.5 ICSI Injection Micropipettes Sales by Application
    2.5.5.1 Global ICSI Injection Micropipettes Sale Market Share by Application (2021-2026)
    2.5.5.2 Global ICSI Injection Micropipettes Revenue and Market Share by Application (2021-2026)
    2.5.5.3 Global ICSI Injection Micropipettes Sale Price by Application (2021-2026)

3 GLOBAL BY COMPANY

3.1 Global ICSI Injection Micropipettes Breakdown Data by Company
  3.1.1 Global ICSI Injection Micropipettes Annual Sales by Company (2021-2026)
  3.1.2 Global ICSI Injection Micropipettes Sales Market Share by Company (2021-2026)
3.2 Global ICSI Injection Micropipettes Annual Revenue by Company (2021-2026)
  3.2.1 Global ICSI Injection Micropipettes Revenue by Company (2021-2026)
  3.2.2 Global ICSI Injection Micropipettes Revenue Market Share by Company (2021-2026)
3.3 Global ICSI Injection Micropipettes Sale Price by Company
3.4 Key Manufacturers ICSI Injection Micropipettes Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers ICSI Injection Micropipettes Product Location Distribution
  3.4.2 Players ICSI Injection Micropipettes Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR ICSI INJECTION MICROPIPETTES BY GEOGRAPHIC REGION

4.1 World Historic ICSI Injection Micropipettes Market Size by Geographic Region (2021-2026)
  4.1.1 Global ICSI Injection Micropipettes Annual Sales by Geographic Region (2021-2026)
  4.1.2 Global ICSI Injection Micropipettes Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic ICSI Injection Micropipettes Market Size by Country/Region (2021-2026)
  4.2.1 Global ICSI Injection Micropipettes Annual Sales by Country/Region (2021-2026)
  4.2.2 Global ICSI Injection Micropipettes Annual Revenue by Country/Region (2021-2026)
4.3 Americas ICSI Injection Micropipettes Sales Growth
4.4 APAC ICSI Injection Micropipettes Sales Growth
4.5 Europe ICSI Injection Micropipettes Sales Growth
4.6 Middle East & Africa ICSI Injection Micropipettes Sales Growth

5 AMERICAS

5.1 Americas ICSI Injection Micropipettes Sales by Country
  5.1.1 Americas ICSI Injection Micropipettes Sales by Country (2021-2026)
  5.1.2 Americas ICSI Injection Micropipettes Revenue by Country (2021-2026)
5.2 Americas ICSI Injection Micropipettes Sales by Type (2021-2026)
5.3 Americas ICSI Injection Micropipettes Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC ICSI Injection Micropipettes Sales by Region
  6.1.1 APAC ICSI Injection Micropipettes Sales by Region (2021-2026)
  6.1.2 APAC ICSI Injection Micropipettes Revenue by Region (2021-2026)
6.2 APAC ICSI Injection Micropipettes Sales by Type (2021-2026)
6.3 APAC ICSI Injection Micropipettes Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe ICSI Injection Micropipettes by Country
  7.1.1 Europe ICSI Injection Micropipettes Sales by Country (2021-2026)
  7.1.2 Europe ICSI Injection Micropipettes Revenue by Country (2021-2026)
7.2 Europe ICSI Injection Micropipettes Sales by Type (2021-2026)
7.3 Europe ICSI Injection Micropipettes Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa ICSI Injection Micropipettes by Country
  8.1.1 Middle East & Africa ICSI Injection Micropipettes Sales by Country (2021-2026)
  8.1.2 Middle East & Africa ICSI Injection Micropipettes Revenue by Country (2021-2026)
8.2 Middle East & Africa ICSI Injection Micropipettes Sales by Type (2021-2026)
8.3 Middle East & Africa ICSI Injection Micropipettes Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of ICSI Injection Micropipettes
10.3 Manufacturing Process Analysis of ICSI Injection Micropipettes
10.4 Industry Chain Structure of ICSI Injection Micropipettes

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 ICSI Injection Micropipettes Distributors
11.3 ICSI Injection Micropipettes Customer

12 WORLD FORECAST REVIEW FOR ICSI INJECTION MICROPIPETTES BY GEOGRAPHIC REGION

12.1 Global ICSI Injection Micropipettes Market Size Forecast by Region
  12.1.1 Global ICSI Injection Micropipettes Forecast by Region (2027-2032)
  12.1.2 Global ICSI Injection Micropipettes Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global ICSI Injection Micropipettes Forecast by Type (2027-2032)
12.7 Global ICSI Injection Micropipettes Forecast by Application (2027-2032)

13 KEY PLAYERS ANALYSIS

13.1 CooperSurgical
  13.1.1 CooperSurgical Company Information
  13.1.2 CooperSurgical ICSI Injection Micropipettes Product Portfolios and Specifications
  13.1.3 CooperSurgical ICSI Injection Micropipettes Sales, Revenue, Price and Gross Margin (2021-2026)
  13.1.4 CooperSurgical Main Business Overview
  13.1.5 CooperSurgical Latest Developments
13.2 Nexpring Health
  13.2.1 Nexpring Health Company Information
  13.2.2 Nexpring Health ICSI Injection Micropipettes Product Portfolios and Specifications
  13.2.3 Nexpring Health ICSI Injection Micropipettes Sales, Revenue, Price and Gross Margin (2021-2026)
  13.2.4 Nexpring Health Main Business Overview
  13.2.5 Nexpring Health Latest Developments
13.3 Vitrolife
  13.3.1 Vitrolife Company Information
  13.3.2 Vitrolife ICSI Injection Micropipettes Product Portfolios and Specifications
  13.3.3 Vitrolife ICSI Injection Micropipettes Sales, Revenue, Price and Gross Margin (2021-2026)
  13.3.4 Vitrolife Main Business Overview
  13.3.5 Vitrolife Latest Developments
13.4 Kitazato
  13.4.1 Kitazato Company Information
  13.4.2 Kitazato ICSI Injection Micropipettes Product Portfolios and Specifications
  13.4.3 Kitazato ICSI Injection Micropipettes Sales, Revenue, Price and Gross Margin (2021-2026)
  13.4.4 Kitazato Main Business Overview
  13.4.5 Kitazato Latest Developments
13.5 Sunlight Medical
  13.5.1 Sunlight Medical Company Information
  13.5.2 Sunlight Medical ICSI Injection Micropipettes Product Portfolios and Specifications
  13.5.3 Sunlight Medical ICSI Injection Micropipettes Sales, Revenue, Price and Gross Margin (2021-2026)
  13.5.4 Sunlight Medical Main Business Overview
  13.5.5 Sunlight Medical Latest Developments
13.6 VITROMED
  13.6.1 VITROMED Company Information
  13.6.2 VITROMED ICSI Injection Micropipettes Product Portfolios and Specifications
  13.6.3 VITROMED ICSI Injection Micropipettes Sales, Revenue, Price and Gross Margin (2021-2026)
  13.6.4 VITROMED Main Business Overview
  13.6.5 VITROMED Latest Developments
13.7 ASTEC
  13.7.1 ASTEC Company Information
  13.7.2 ASTEC ICSI Injection Micropipettes Product Portfolios and Specifications
  13.7.3 ASTEC ICSI Injection Micropipettes Sales, Revenue, Price and Gross Margin (2021-2026)
  13.7.4 ASTEC Main Business Overview
  13.7.5 ASTEC Latest Developments
13.8 Labotect
  13.8.1 Labotect Company Information
  13.8.2 Labotect ICSI Injection Micropipettes Product Portfolios and Specifications
  13.8.3 Labotect ICSI Injection Micropipettes Sales, Revenue, Price and Gross Margin (2021-2026)
  13.8.4 Labotect Main Business Overview
  13.8.5 Labotect Latest Developments
13.9 Thomas Medical
  13.9.1 Thomas Medical Company Information
  13.9.2 Thomas Medical ICSI Injection Micropipettes Product Portfolios and Specifications
  13.9.3 Thomas Medical ICSI Injection Micropipettes Sales, Revenue, Price and Gross Margin (2021-2026)
  13.9.4 Thomas Medical Main Business Overview
  13.9.5 Thomas Medical Latest Developments
13.10 Microtech IVF
  13.10.1 Microtech IVF Company Information
  13.10.2 Microtech IVF ICSI Injection Micropipettes Product Portfolios and Specifications
  13.10.3 Microtech IVF ICSI Injection Micropipettes Sales, Revenue, Price and Gross Margin (2021-2026)
  13.10.4 Microtech IVF Main Business Overview
  13.10.5 Microtech IVF Latest Developments
13.11 Synga
  13.11.1 Synga Company Information
  13.11.2 Synga ICSI Injection Micropipettes Product Portfolios and Specifications
  13.11.3 Synga ICSI Injection Micropipettes Sales, Revenue, Price and Gross Margin (2021-2026)
  13.11.4 Synga Main Business Overview
  13.11.5 Synga Latest Developments
13.12 ARSCI
  13.12.1 ARSCI Company Information
  13.12.2 ARSCI ICSI Injection Micropipettes Product Portfolios and Specifications
  13.12.3 ARSCI ICSI Injection Micropipettes Sales, Revenue, Price and Gross Margin (2021-2026)
  13.12.4 ARSCI Main Business Overview
  13.12.5 ARSCI Latest Developments
13.13 Optimas
  13.13.1 Optimas Company Information
  13.13.2 Optimas ICSI Injection Micropipettes Product Portfolios and Specifications
  13.13.3 Optimas ICSI Injection Micropipettes Sales, Revenue, Price and Gross Margin (2021-2026)
  13.13.4 Optimas Main Business Overview
  13.13.5 Optimas Latest Developments
13.14 ICSION Medical
  13.14.1 ICSION Medical Company Information
  13.14.2 ICSION Medical ICSI Injection Micropipettes Product Portfolios and Specifications
  13.14.3 ICSION Medical ICSI Injection Micropipettes Sales, Revenue, Price and Gross Margin (2021-2026)
  13.14.4 ICSION Medical Main Business Overview
  13.14.5 ICSION Medical Latest Developments
13.15 Monash Biotech
  13.15.1 Monash Biotech Company Information
  13.15.2 Monash Biotech ICSI Injection Micropipettes Product Portfolios and Specifications
  13.15.3 Monash Biotech ICSI Injection Micropipettes Sales, Revenue, Price and Gross Margin (2021-2026)
  13.15.4 Monash Biotech Main Business Overview
  13.15.5 Monash Biotech Latest Developments
13.16 Reproline medical
  13.16.1 Reproline medical Company Information
  13.16.2 Reproline medical ICSI Injection Micropipettes Product Portfolios and Specifications
  13.16.3 Reproline medical ICSI Injection Micropipettes Sales, Revenue, Price and Gross Margin (2021-2026)
  13.16.4 Reproline medical Main Business Overview
  13.16.5 Reproline medical Latest Developments
13.17 TechBruein
  13.17.1 TechBruein Company Information
  13.17.2 TechBruein ICSI Injection Micropipettes Product Portfolios and Specifications
  13.17.3 TechBruein ICSI Injection Micropipettes Sales, Revenue, Price and Gross Margin (2021-2026)
  13.17.4 TechBruein Main Business Overview
  13.17.5 TechBruein Latest Developments
13.18 SASOmed
  13.18.1 SASOmed Company Information
  13.18.2 SASOmed ICSI Injection Micropipettes Product Portfolios and Specifications
  13.18.3 SASOmed ICSI Injection Micropipettes Sales, Revenue, Price and Gross Margin (2021-2026)
  13.18.4 SASOmed Main Business Overview
  13.18.5 SASOmed Latest Developments
13.19 VitaVitro
  13.19.1 VitaVitro Company Information
  13.19.2 VitaVitro ICSI Injection Micropipettes Product Portfolios and Specifications
  13.19.3 VitaVitro ICSI Injection Micropipettes Sales, Revenue, Price and Gross Margin (2021-2026)
  13.19.4 VitaVitro Main Business Overview
  13.19.5 VitaVitro Latest Developments
13.20 DEWIN
  13.20.1 DEWIN Company Information
  13.20.2 DEWIN ICSI Injection Micropipettes Product Portfolios and Specifications
  13.20.3 DEWIN ICSI Injection Micropipettes Sales, Revenue, Price and Gross Margin (2021-2026)
  13.20.4 DEWIN Main Business Overview
  13.20.5 DEWIN Latest Developments
13.21 WEGO Shingene Medical
  13.21.1 WEGO Shingene Medical Company Information
  13.21.2 WEGO Shingene Medical ICSI Injection Micropipettes Product Portfolios and Specifications
  13.21.3 WEGO Shingene Medical ICSI Injection Micropipettes Sales, Revenue, Price and Gross Margin (2021-2026)
  13.21.4 WEGO Shingene Medical Main Business Overview
  13.21.5 WEGO Shingene Medical Latest Developments
13.22 Lingen Precision Medical Products
  13.22.1 Lingen Precision Medical Products Company Information
  13.22.2 Lingen Precision Medical Products ICSI Injection Micropipettes Product Portfolios and Specifications
  13.22.3 Lingen Precision Medical Products ICSI Injection Micropipettes Sales, Revenue, Price and Gross Margin (2021-2026)
  13.22.4 Lingen Precision Medical Products Main Business Overview
  13.22.5 Lingen Precision Medical Products Latest Developments
13.23 Diagens Bio
  13.23.1 Diagens Bio Company Information
  13.23.2 Diagens Bio ICSI Injection Micropipettes Product Portfolios and Specifications
  13.23.3 Diagens Bio ICSI Injection Micropipettes Sales, Revenue, Price and Gross Margin (2021-2026)
  13.23.4 Diagens Bio Main Business Overview
  13.23.5 Diagens Bio Latest Developments
13.24 Minvitro
  13.24.1 Minvitro Company Information
  13.24.2 Minvitro ICSI Injection Micropipettes Product Portfolios and Specifications
  13.24.3 Minvitro ICSI Injection Micropipettes Sales, Revenue, Price and Gross Margin (2021-2026)
  13.24.4 Minvitro Main Business Overview
  13.24.5 Minvitro Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. ICSI Injection Micropipettes Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. ICSI Injection Micropipettes Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Spiked
Table 4. Major Players of Non-Spiked
Table 5. Global ICSI Injection Micropipettes Sales by Type (2021-2026) & (K Units)
Table 6. Global ICSI Injection Micropipettes Sales Market Share by Type (2021-2026)
Table 7. Global ICSI Injection Micropipettes Revenue by Type (2021-2026) & ($ million)
Table 8. Global ICSI Injection Micropipettes Revenue Market Share by Type (2021-2026)
Table 9. Global ICSI Injection Micropipettes Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players of <5.0 ?m
Table 11. Major Players of 5.0–<6.0 ?m
Table 12. Major Players of ?6.0 ?m
Table 13. Global ICSI Injection Micropipettes Sales by Inner Diameter (2021-2026) & (K Units)
Table 14. Global ICSI Injection Micropipettes Sales Market Share by Inner Diameter (2021-2026)
Table 15. Global ICSI Injection Micropipettes Revenue by Inner Diameter (2021-2026) & ($ million)
Table 16. Global ICSI Injection Micropipettes Revenue Market Share by Inner Diameter (2021-2026)
Table 17. Global ICSI Injection Micropipettes Sale Price by Inner Diameter (2021-2026) & (US$/Unit)
Table 18. Major Players of Long Parallel-Wall
Table 19. Major Players of Short Parallel-Wall
Table 20. Major Players of Rigid-Taper
Table 21. Global ICSI Injection Micropipettes Sales by Taper Design (2021-2026) & (K Units)
Table 22. Global ICSI Injection Micropipettes Sales Market Share by Taper Design (2021-2026)
Table 23. Global ICSI Injection Micropipettes Revenue by Taper Design (2021-2026) & ($ million)
Table 24. Global ICSI Injection Micropipettes Revenue Market Share by Taper Design (2021-2026)
Table 25. Global ICSI Injection Micropipettes Sale Price by Taper Design (2021-2026) & (US$/Unit)
Table 26. Global ICSI Injection Micropipettes Sale by Application (2021-2026) & (K Units)
Table 27. Global ICSI Injection Micropipettes Sale Market Share by Application (2021-2026)
Table 28. Global ICSI Injection Micropipettes Revenue by Application (2021-2026) & ($ million)
Table 29. Global ICSI Injection Micropipettes Revenue Market Share by Application (2021-2026)
Table 30. Global ICSI Injection Micropipettes Sale Price by Application (2021-2026) & (US$/Unit)
Table 31. Global ICSI Injection Micropipettes Sales by Company (2021-2026) & (K Units)
Table 32. Global ICSI Injection Micropipettes Sales Market Share by Company (2021-2026)
Table 33. Global ICSI Injection Micropipettes Revenue by Company (2021-2026) & ($ millions)
Table 34. Global ICSI Injection Micropipettes Revenue Market Share by Company (2021-2026)
Table 35. Global ICSI Injection Micropipettes Sale Price by Company (2021-2026) & (US$/Unit)
Table 36. Key Manufacturers ICSI Injection Micropipettes Producing Area Distribution and Sales Area
Table 37. Players ICSI Injection Micropipettes Products Offered
Table 38. ICSI Injection Micropipettes Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 39. New Products and Potential Entrants
Table 40. Market M&A Activity & Strategy
Table 41. Global ICSI Injection Micropipettes Sales by Geographic Region (2021-2026) & (K Units)
Table 42. Global ICSI Injection Micropipettes Sales Market Share Geographic Region (2021-2026)
Table 43. Global ICSI Injection Micropipettes Revenue by Geographic Region (2021-2026) & ($ millions)
Table 44. Global ICSI Injection Micropipettes Revenue Market Share by Geographic Region (2021-2026)
Table 45. Global ICSI Injection Micropipettes Sales by Country/Region (2021-2026) & (K Units)
Table 46. Global ICSI Injection Micropipettes Sales Market Share by Country/Region (2021-2026)
Table 47. Global ICSI Injection Micropipettes Revenue by Country/Region (2021-2026) & ($ millions)
Table 48. Global ICSI Injection Micropipettes Revenue Market Share by Country/Region (2021-2026)
Table 49. Americas ICSI Injection Micropipettes Sales by Country (2021-2026) & (K Units)
Table 50. Americas ICSI Injection Micropipettes Sales Market Share by Country (2021-2026)
Table 51. Americas ICSI Injection Micropipettes Revenue by Country (2021-2026) & ($ millions)
Table 52. Americas ICSI Injection Micropipettes Sales by Type (2021-2026) & (K Units)
Table 53. Americas ICSI Injection Micropipettes Sales by Application (2021-2026) & (K Units)
Table 54. APAC ICSI Injection Micropipettes Sales by Region (2021-2026) & (K Units)
Table 55. APAC ICSI Injection Micropipettes Sales Market Share by Region (2021-2026)
Table 56. APAC ICSI Injection Micropipettes Revenue by Region (2021-2026) & ($ millions)
Table 57. APAC ICSI Injection Micropipettes Sales by Type (2021-2026) & (K Units)
Table 58. APAC ICSI Injection Micropipettes Sales by Application (2021-2026) & (K Units)
Table 59. Europe ICSI Injection Micropipettes Sales by Country (2021-2026) & (K Units)
Table 60. Europe ICSI Injection Micropipettes Revenue by Country (2021-2026) & ($ millions)
Table 61. Europe ICSI Injection Micropipettes Sales by Type (2021-2026) & (K Units)
Table 62. Europe ICSI Injection Micropipettes Sales by Application (2021-2026) & (K Units)
Table 63. Middle East & Africa ICSI Injection Micropipettes Sales by Country (2021-2026) & (K Units)
Table 64. Middle East & Africa ICSI Injection Micropipettes Revenue Market Share by Country (2021-2026)
Table 65. Middle East & Africa ICSI Injection Micropipettes Sales by Type (2021-2026) & (K Units)
Table 66. Middle East & Africa ICSI Injection Micropipettes Sales by Application (2021-2026) & (K Units)
Table 67. Key Market Drivers & Growth Opportunities of ICSI Injection Micropipettes
Table 68. Key Market Challenges & Risks of ICSI Injection Micropipettes
Table 69. Key Industry Trends of ICSI Injection Micropipettes
Table 70. ICSI Injection Micropipettes Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. ICSI Injection Micropipettes Distributors List
Table 73. ICSI Injection Micropipettes Customer List
Table 74. Global ICSI Injection Micropipettes Sales Forecast by Region (2027-2032) & (K Units)
Table 75. Global ICSI Injection Micropipettes Revenue Forecast by Region (2027-2032) & ($ millions)
Table 76. Americas ICSI Injection Micropipettes Sales Forecast by Country (2027-2032) & (K Units)
Table 77. Americas ICSI Injection Micropipettes Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 78. APAC ICSI Injection Micropipettes Sales Forecast by Region (2027-2032) & (K Units)
Table 79. APAC ICSI Injection Micropipettes Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 80. Europe ICSI Injection Micropipettes Sales Forecast by Country (2027-2032) & (K Units)
Table 81. Europe ICSI Injection Micropipettes Revenue Forecast by Country (2027-2032) & ($ millions)
Table 82. Middle East & Africa ICSI Injection Micropipettes Sales Forecast by Country (2027-2032) & (K Units)
Table 83. Middle East & Africa ICSI Injection Micropipettes Revenue Forecast by Country (2027-2032) & ($ millions)
Table 84. Global ICSI Injection Micropipettes Sales Forecast by Type (2027-2032) & (K Units)
Table 85. Global ICSI Injection Micropipettes Revenue Forecast by Type (2027-2032) & ($ millions)
Table 86. Global ICSI Injection Micropipettes Sales Forecast by Application (2027-2032) & (K Units)
Table 87. Global ICSI Injection Micropipettes Revenue Forecast by Application (2027-2032) & ($ millions)
Table 88. CooperSurgical Basic Information, ICSI Injection Micropipettes Manufacturing Base, Sales Area and Its Competitors
Table 89. CooperSurgical ICSI Injection Micropipettes Product Portfolios and Specifications
Table 90. CooperSurgical ICSI Injection Micropipettes Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. CooperSurgical Main Business
Table 92. CooperSurgical Latest Developments
Table 93. Nexpring Health Basic Information, ICSI Injection Micropipettes Manufacturing Base, Sales Area and Its Competitors
Table 94. Nexpring Health ICSI Injection Micropipettes Product Portfolios and Specifications
Table 95. Nexpring Health ICSI Injection Micropipettes Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Nexpring Health Main Business
Table 97. Nexpring Health Latest Developments
Table 98. Vitrolife Basic Information, ICSI Injection Micropipettes Manufacturing Base, Sales Area and Its Competitors
Table 99. Vitrolife ICSI Injection Micropipettes Product Portfolios and Specifications
Table 100. Vitrolife ICSI Injection Micropipettes Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Vitrolife Main Business
Table 102. Vitrolife Latest Developments
Table 103. Kitazato Basic Information, ICSI Injection Micropipettes Manufacturing Base, Sales Area and Its Competitors
Table 104. Kitazato ICSI Injection Micropipettes Product Portfolios and Specifications
Table 105. Kitazato ICSI Injection Micropipettes Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. Kitazato Main Business
Table 107. Kitazato Latest Developments
Table 108. Sunlight Medical Basic Information, ICSI Injection Micropipettes Manufacturing Base, Sales Area and Its Competitors
Table 109. Sunlight Medical ICSI Injection Micropipettes Product Portfolios and Specifications
Table 110. Sunlight Medical ICSI Injection Micropipettes Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Sunlight Medical Main Business
Table 112. Sunlight Medical Latest Developments
Table 113. VITROMED Basic Information, ICSI Injection Micropipettes Manufacturing Base, Sales Area and Its Competitors
Table 114. VITROMED ICSI Injection Micropipettes Product Portfolios and Specifications
Table 115. VITROMED ICSI Injection Micropipettes Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. VITROMED Main Business
Table 117. VITROMED Latest Developments
Table 118. ASTEC Basic Information, ICSI Injection Micropipettes Manufacturing Base, Sales Area and Its Competitors
Table 119. ASTEC ICSI Injection Micropipettes Product Portfolios and Specifications
Table 120. ASTEC ICSI Injection Micropipettes Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. ASTEC Main Business
Table 122. ASTEC Latest Developments
Table 123. Labotect Basic Information, ICSI Injection Micropipettes Manufacturing Base, Sales Area and Its Competitors
Table 124. Labotect ICSI Injection Micropipettes Product Portfolios and Specifications
Table 125. Labotect ICSI Injection Micropipettes Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. Labotect Main Business
Table 127. Labotect Latest Developments
Table 128. Thomas Medical Basic Information, ICSI Injection Micropipettes Manufacturing Base, Sales Area and Its Competitors
Table 129. Thomas Medical ICSI Injection Micropipettes Product Portfolios and Specifications
Table 130. Thomas Medical ICSI Injection Micropipettes Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 131. Thomas Medical Main Business
Table 132. Thomas Medical Latest Developments
Table 133. Microtech IVF Basic Information, ICSI Injection Micropipettes Manufacturing Base, Sales Area and Its Competitors
Table 134. Microtech IVF ICSI Injection Micropipettes Product Portfolios and Specifications
Table 135. Microtech IVF ICSI Injection Micropipettes Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 136. Microtech IVF Main Business
Table 137. Microtech IVF Latest Developments
Table 138. Synga Basic Information, ICSI Injection Micropipettes Manufacturing Base, Sales Area and Its Competitors
Table 139. Synga ICSI Injection Micropipettes Product Portfolios and Specifications
Table 140. Synga ICSI Injection Micropipettes Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 141. Synga Main Business
Table 142. Synga Latest Developments
Table 143. ARSCI Basic Information, ICSI Injection Micropipettes Manufacturing Base, Sales Area and Its Competitors
Table 144. ARSCI ICSI Injection Micropipettes Product Portfolios and Specifications
Table 145. ARSCI ICSI Injection Micropipettes Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 146. ARSCI Main Business
Table 147. ARSCI Latest Developments
Table 148. Optimas Basic Information, ICSI Injection Micropipettes Manufacturing Base, Sales Area and Its Competitors
Table 149. Optimas ICSI Injection Micropipettes Product Portfolios and Specifications
Table 150. Optimas ICSI Injection Micropipettes Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 151. Optimas Main Business
Table 152. Optimas Latest Developments
Table 153. ICSION Medical Basic Information, ICSI Injection Micropipettes Manufacturing Base, Sales Area and Its Competitors
Table 154. ICSION Medical ICSI Injection Micropipettes Product Portfolios and Specifications
Table 155. ICSION Medical ICSI Injection Micropipettes Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 156. ICSION Medical Main Business
Table 157. ICSION Medical Latest Developments
Table 158. Monash Biotech Basic Information, ICSI Injection Micropipettes Manufacturing Base, Sales Area and Its Competitors
Table 159. Monash Biotech ICSI Injection Micropipettes Product Portfolios and Specifications
Table 160. Monash Biotech ICSI Injection Micropipettes Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 161. Monash Biotech Main Business
Table 162. Monash Biotech Latest Developments
Table 163. Reproline medical Basic Information, ICSI Injection Micropipettes Manufacturing Base, Sales Area and Its Competitors
Table 164. Reproline medical ICSI Injection Micropipettes Product Portfolios and Specifications
Table 165. Reproline medical ICSI Injection Micropipettes Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 166. Reproline medical Main Business
Table 167. Reproline medical Latest Developments
Table 168. TechBruein Basic Information, ICSI Injection Micropipettes Manufacturing Base, Sales Area and Its Competitors
Table 169. TechBruein ICSI Injection Micropipettes Product Portfolios and Specifications
Table 170. TechBruein ICSI Injection Micropipettes Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 171. TechBruein Main Business
Table 172. TechBruein Latest Developments
Table 173. SASOmed Basic Information, ICSI Injection Micropipettes Manufacturing Base, Sales Area and Its Competitors
Table 174. SASOmed ICSI Injection Micropipettes Product Portfolios and Specifications
Table 175. SASOmed ICSI Injection Micropipettes Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 176. SASOmed Main Business
Table 177. SASOmed Latest Developments
Table 178. VitaVitro Basic Information, ICSI Injection Micropipettes Manufacturing Base, Sales Area and Its Competitors
Table 179. VitaVitro ICSI Injection Micropipettes Product Portfolios and Specifications
Table 180. VitaVitro ICSI Injection Micropipettes Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 181. VitaVitro Main Business
Table 182. VitaVitro Latest Developments
Table 183. DEWIN Basic Information, ICSI Injection Micropipettes Manufacturing Base, Sales Area and Its Competitors
Table 184. DEWIN ICSI Injection Micropipettes Product Portfolios and Specifications
Table 185. DEWIN ICSI Injection Micropipettes Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 186. DEWIN Main Business
Table 187. DEWIN Latest Developments
Table 188. WEGO Shingene Medical Basic Information, ICSI Injection Micropipettes Manufacturing Base, Sales Area and Its Competitors
Table 189. WEGO Shingene Medical ICSI Injection Micropipettes Product Portfolios and Specifications
Table 190. WEGO Shingene Medical ICSI Injection Micropipettes Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 191. WEGO Shingene Medical Main Business
Table 192. WEGO Shingene Medical Latest Developments
Table 193. Lingen Precision Medical Products Basic Information, ICSI Injection Micropipettes Manufacturing Base, Sales Area and Its Competitors
Table 194. Lingen Precision Medical Products ICSI Injection Micropipettes Product Portfolios and Specifications
Table 195. Lingen Precision Medical Products ICSI Injection Micropipettes Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 196. Lingen Precision Medical Products Main Business
Table 197. Lingen Precision Medical Products Latest Developments
Table 198. Diagens Bio Basic Information, ICSI Injection Micropipettes Manufacturing Base, Sales Area and Its Competitors
Table 199. Diagens Bio ICSI Injection Micropipettes Product Portfolios and Specifications
Table 200. Diagens Bio ICSI Injection Micropipettes Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 201. Diagens Bio Main Business
Table 202. Diagens Bio Latest Developments
Table 203. Minvitro Basic Information, ICSI Injection Micropipettes Manufacturing Base, Sales Area and Its Competitors
Table 204. Minvitro ICSI Injection Micropipettes Product Portfolios and Specifications
Table 205. Minvitro ICSI Injection Micropipettes Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 206. Minvitro Main Business
Table 207. Minvitro Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of ICSI Injection Micropipettes
Figure 2. ICSI Injection Micropipettes Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global ICSI Injection Micropipettes Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global ICSI Injection Micropipettes Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. ICSI Injection Micropipettes Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. ICSI Injection Micropipettes Sales Market Share by Country/Region (2025)
Figure 10. ICSI Injection Micropipettes Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Spiked
Figure 12. Product Picture of Non-Spiked
Figure 13. Global ICSI Injection Micropipettes Sales Market Share by Type in 2026
Figure 14. Global ICSI Injection Micropipettes Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of <5.0 ?m
Figure 16. Product Picture of 5.0–<6.0 ?m
Figure 17. Product Picture of ?6.0 ?m
Figure 18. Global ICSI Injection Micropipettes Sales Market Share by Inner Diameter in 2026
Figure 19. Global ICSI Injection Micropipettes Revenue Market Share by Inner Diameter (2021-2026)
Figure 20. Product Picture of Long Parallel-Wall
Figure 21. Product Picture of Short Parallel-Wall
Figure 22. Product Picture of Rigid-Taper
Figure 23. Global ICSI Injection Micropipettes Sales Market Share by Taper Design in 2026
Figure 24. Global ICSI Injection Micropipettes Revenue Market Share by Taper Design (2021-2026)
Figure 25. ICSI Injection Micropipettes Consumed in Fertility Clinics and IVF Centers
Figure 26. Global ICSI Injection Micropipettes Market: Fertility Clinics and IVF Centers (2021-2026) & (K Units)
Figure 27. ICSI Injection Micropipettes Consumed in Hospital-Based Reproductive Medicine Centers
Figure 28. Global ICSI Injection Micropipettes Market: Hospital-Based Reproductive Medicine Centers (2021-2026) & (K Units)
Figure 29. ICSI Injection Micropipettes Consumed in Academic and Research Laboratories
Figure 30. Global ICSI Injection Micropipettes Market: Academic and Research Laboratories (2021-2026) & (K Units)
Figure 31. ICSI Injection Micropipettes Consumed in Others
Figure 32. Global ICSI Injection Micropipettes Market: Others (2021-2026) & (K Units)
Figure 33. Global ICSI Injection Micropipettes Sale Market Share by Application (2025)
Figure 34. Global ICSI Injection Micropipettes Revenue Market Share by Application in 2025
Figure 35. ICSI Injection Micropipettes Sales by Company in 2025 (K Units)
Figure 36. Global ICSI Injection Micropipettes Sales Market Share by Company in 2025
Figure 37. ICSI Injection Micropipettes Revenue by Company in 2025 ($ millions)
Figure 38. Global ICSI Injection Micropipettes Revenue Market Share by Company in 2025
Figure 39. Global ICSI Injection Micropipettes Sales Market Share by Geographic Region (2021-2026)
Figure 40. Global ICSI Injection Micropipettes Revenue Market Share by Geographic Region in 2025
Figure 41. Americas ICSI Injection Micropipettes Sales 2021-2026 (K Units)
Figure 42. Americas ICSI Injection Micropipettes Revenue 2021-2026 ($ millions)
Figure 43. APAC ICSI Injection Micropipettes Sales 2021-2026 (K Units)
Figure 44. APAC ICSI Injection Micropipettes Revenue 2021-2026 ($ millions)
Figure 45. Europe ICSI Injection Micropipettes Sales 2021-2026 (K Units)
Figure 46. Europe ICSI Injection Micropipettes Revenue 2021-2026 ($ millions)
Figure 47. Middle East & Africa ICSI Injection Micropipettes Sales 2021-2026 (K Units)
Figure 48. Middle East & Africa ICSI Injection Micropipettes Revenue 2021-2026 ($ millions)
Figure 49. Americas ICSI Injection Micropipettes Sales Market Share by Country in 2025
Figure 50. Americas ICSI Injection Micropipettes Revenue Market Share by Country (2021-2026)
Figure 51. Americas ICSI Injection Micropipettes Sales Market Share by Type (2021-2026)
Figure 52. Americas ICSI Injection Micropipettes Sales Market Share by Application (2021-2026)
Figure 53. United States ICSI Injection Micropipettes Revenue Growth 2021-2026 ($ millions)
Figure 54. Canada ICSI Injection Micropipettes Revenue Growth 2021-2026 ($ millions)
Figure 55. Mexico ICSI Injection Micropipettes Revenue Growth 2021-2026 ($ millions)
Figure 56. Brazil ICSI Injection Micropipettes Revenue Growth 2021-2026 ($ millions)
Figure 57. APAC ICSI Injection Micropipettes Sales Market Share by Region in 2025
Figure 58. APAC ICSI Injection Micropipettes Revenue Market Share by Region (2021-2026)
Figure 59. APAC ICSI Injection Micropipettes Sales Market Share by Type (2021-2026)
Figure 60. APAC ICSI Injection Micropipettes Sales Market Share by Application (2021-2026)
Figure 61. China ICSI Injection Micropipettes Revenue Growth 2021-2026 ($ millions)
Figure 62. Japan ICSI Injection Micropipettes Revenue Growth 2021-2026 ($ millions)
Figure 63. South Korea ICSI Injection Micropipettes Revenue Growth 2021-2026 ($ millions)
Figure 64. Southeast Asia ICSI Injection Micropipettes Revenue Growth 2021-2026 ($ millions)
Figure 65. India ICSI Injection Micropipettes Revenue Growth 2021-2026 ($ millions)
Figure 66. Australia ICSI Injection Micropipettes Revenue Growth 2021-2026 ($ millions)
Figure 67. China Taiwan ICSI Injection Micropipettes Revenue Growth 2021-2026 ($ millions)
Figure 68. Europe ICSI Injection Micropipettes Sales Market Share by Country in 2025
Figure 69. Europe ICSI Injection Micropipettes Revenue Market Share by Country (2021-2026)
Figure 70. Europe ICSI Injection Micropipettes Sales Market Share by Type (2021-2026)
Figure 71. Europe ICSI Injection Micropipettes Sales Market Share by Application (2021-2026)
Figure 72. Germany ICSI Injection Micropipettes Revenue Growth 2021-2026 ($ millions)
Figure 73. France ICSI Injection Micropipettes Revenue Growth 2021-2026 ($ millions)
Figure 74. UK ICSI Injection Micropipettes Revenue Growth 2021-2026 ($ millions)
Figure 75. Italy ICSI Injection Micropipettes Revenue Growth 2021-2026 ($ millions)
Figure 76. Russia ICSI Injection Micropipettes Revenue Growth 2021-2026 ($ millions)
Figure 77. Middle East & Africa ICSI Injection Micropipettes Sales Market Share by Country (2021-2026)
Figure 78. Middle East & Africa ICSI Injection Micropipettes Sales Market Share by Type (2021-2026)
Figure 79. Middle East & Africa ICSI Injection Micropipettes Sales Market Share by Application (2021-2026)
Figure 80. Egypt ICSI Injection Micropipettes Revenue Growth 2021-2026 ($ millions)
Figure 81. South Africa ICSI Injection Micropipettes Revenue Growth 2021-2026 ($ millions)
Figure 82. Israel ICSI Injection Micropipettes Revenue Growth 2021-2026 ($ millions)
Figure 83. Turkey ICSI Injection Micropipettes Revenue Growth 2021-2026 ($ millions)
Figure 84. GCC Countries ICSI Injection Micropipettes Revenue Growth 2021-2026 ($ millions)
Figure 85. Manufacturing Cost Structure Analysis of ICSI Injection Micropipettes in 2026
Figure 86. Manufacturing Process Analysis of ICSI Injection Micropipettes
Figure 87. Industry Chain Structure of ICSI Injection Micropipettes
Figure 88. Channels of Distribution
Figure 89. Global ICSI Injection Micropipettes Sales Market Forecast by Region (2027-2032)
Figure 90. Global ICSI Injection Micropipettes Revenue Market Share Forecast by Region (2027-2032)
Figure 91. Global ICSI Injection Micropipettes Sales Market Share Forecast by Type (2027-2032)
Figure 92. Global ICSI Injection Micropipettes Revenue Market Share Forecast by Type (2027-2032)
Figure 93. Global ICSI Injection Micropipettes Sales Market Share Forecast by Application (2027-2032)
Figure 94. Global ICSI Injection Micropipettes Revenue Market Share Forecast by Application (2027-2032)